Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Piramal PharmaPlans New Manufacturing Facility in Michigan
Piramal Pharma Solutions plans to expand with the addition of a new manufacturing facility located in Michigan
SeqirusConstructs World Class Vaccine Manufacturing Facility in Australia
Seqirus, a global leader in influenza prevention and influenza pandemic responseplans to construct a new nextgeneration vaccine manufacturing facility The new manufacturing facility will be located in Australia
Samsung Biologics Constructs Super Plant 4 in South Korea
Samsung Biologics plans to open the most innovative biomanufacturing facility with the addition of super plant 4 The modern super plant 4 will be located in Incheon, South Korea
Cambrex to Expand Large Scale API Manufacturing Capacity in US
Cambrex plans to invest US$50 million to expand new midscale and largescale API manufacturing capacity The site will be located in Iowa, US
Vibalogics Invests US$150million to Expand Virotherapy Facility in Boston
Vibalogics with an investment of US$ 150 million plans to enter the US region to expand Virotherapy Facility The new facility will be located in Boston
Minaris Regenerative Medicine Opens New Manufacturing Sites in Europe and Asia
Minaris Regenerative Medicine plans to invest US$645 million to open new manufacturing facilities in Asia and Europe This expansion increases the cell and gene manufacturing capabilities
Metrics Expands Manufacturing Facility in North Carolina
Metrics Contract Services Metrics plans to invest US$10 million for the expansion of a novel oral solid dosage manufacturing facility in Greenville, North Carolina
Thermo Fisher Scientific Plans to Expand New Facility in Singapore
Thermo Fisher Scientific Inc, plans to invest US$130 million to expand a new facility in Singapore The expanded sterile filling capacity will be dedicated for developing Therapies and Vaccines
Romark Constructs New Manufacturing Facility in Manati
Romark constructs a new stateoftheart facility located in Manati, Puerto Rico The new manufacturing facility is estimated with an amount of more than US$80 million
Merck Invests US$715 million in New Facility at Madison,USA
Merck with an investment of US$715 million plans for the expansion of Antibodydrug Conjugates ADC manufacturing The new manufacturing facility will be located in Madison, Wisconsin, USA
